Emergent Biosolutions EBS Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Emergent Biosolutions's retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Emergent Biosolutions's retained earnings?
- Emergent Biosolutions (EBS) reported retained earnings of -$153M in Q1 2026.
- How has Emergent Biosolutions's retained earnings changed year-over-year?
- Emergent Biosolutions's retained earnings decreased by 6.0% year-over-year, from -$144.4M to -$153M.
- What is the long-term trend for Emergent Biosolutions's retained earnings?
- Over 5 years (2020 to 2025), Emergent Biosolutions's retained earnings has grown at a -26.1% compound annual growth rate (CAGR), from $726.9M to -$159.8M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.